About Us
You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you'll help scale cures to patients that need them sooner.
We've developed fully-automated cell manufacturing sites, powered by custom robotics - to scale treatments to millions of patients. Last year, patients were cured of diseases like Parkinson's and vision loss using stem-cell derived cells - but today these Regenerative Medicines are produced by hand, meaning they're too expensive and hard to scale.
With our automated manufacturing sites, these therapies can now be scaled globally at low cost. We've announced partnerships across multiple therapies so far ranging from Parkinson's, to hearing loss, to bone repair - and raised $35m to expand into the market faster, and accelerate our development! Within the next 12 months, neurons grown on our machines will be going into Parkinson's patient brains.
We've assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.